Sorensen Mel 4
4 · Galera Therapeutics, Inc. · Filed Mar 14, 2023
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-03-10$1.68/sh+100,000$168,120→ 332,044 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.